Clara Benavent-Bofill

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

E. Ruiz-Mateos, F. Vidal, J. Burgos, 2022, Clinical and translational medicine.